Acta neurologica Scandinavica
-
Acta Neurol. Scand. · Sep 2006
Randomized Controlled Trial Multicenter StudyA randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy.
To evaluate the efficacy and safety of oxcarbazepine (1200 mg/day) in patients with painful diabetic neuropathy in a multicentre, double-blind, placebo-controlled, 16-week study. ⋯ In this study, no statistically significant difference in therapeutic effect was observed between oxcarbazepine (1200 mg/day) and placebo. However, further studies are necessary to assess the effective dose range of oxcarbazepine in the treatment of painful diabetic neuropathy.